Category: Uncategorized

Helocyte, Inc., a partner company of Fortress Biotech, is developing Triplex for the treatment of cytomegalovirus Clinical trial will evaluate whether Triplex, which was developed by City of Hope, is safe and effective in eliciting a CMV-specific immune response in people living with HIV and is thus able to reduce CMV replication New York, NY […]

DATA FROM PHASE 1 TRIAL OF TRIPLEX VACCINE FOR CONTROL OF CYTOMEGALOVIRUS PUBLISHED IN BLOOD

HELOCYTE ANNOUNCES CORPORATE AND CLINICAL MILESTONES

FORTRESS BIOTECH (f/k/a Coronado Biosciences) FORMS NEW SUBSIDIARY, HELOCYTE, INC. (f/k/a DiaVax Biosciences) TO DEVELOP NOVEL IMMUNOTHERAPIES FOR CYTOMEGALOVIRUS